Your browser doesn't support javascript.
loading
Can Immune Checkpoint Inhibitors Pave the New Way for "Conversion Surgery" in Unresectable Esophageal Cancer?
Sato, Sho; Shimada, Hideaki.
Affiliation
  • Sato S; Department of Surgery, Yokohama City University Gastroenterological Center, Yokohama, Japan.
  • Shimada H; Department of Surgery, Toho University School of Medicine, Tokyo, Japan. hideaki.shimada@med.toho-u.ac.jp.
Ann Surg Oncol ; 31(10): 6357-6358, 2024 Oct.
Article in En | MEDLINE | ID: mdl-38858291
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Immune Checkpoint Inhibitors Limits: Humans Language: En Journal: Ann Surg Oncol / Ann. surg. oncol / Annals of surgical oncology Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Japón Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Immune Checkpoint Inhibitors Limits: Humans Language: En Journal: Ann Surg Oncol / Ann. surg. oncol / Annals of surgical oncology Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Japón Country of publication: Estados Unidos